Social Cognitive Assessment in Autism and Schizophrenia ((ClaCoS))
Schizophrenia
About this trial
This is an interventional screening trial for Schizophrenia focused on measuring schizophrenia
Eligibility Criteria
Inclusion Criteria:
- Aged 18-45 years old
- No psychiatric or neurologic conditions or comorbidity
- No relatives with people with people with history of neuropsychiatric disease
- French native language or education in a French school since the first year of primary school
- Consent to participate to the study
Exclusion Criteria:
- Aged 18-45 years old
- Patients with schizophrenia: diagnosis assessed with DSM5 criteria
- No modification of psychotropic treatment during the month before inclusion
- French native language or education in a French school since the first year of primary school
- Consent to participate to the study and agreement of the legal guardian
Sites / Locations
- Professeur FRANCK Nicolas
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Placebo Comparator
schizophrenia
autism
healthy controls
this project is to assess relevance of ClaCoS in schizophrenia compared to healthy controls, and to analyze links between social cognition and both neurocognition and symptoms, (2) to collect data in a large sample of healthy controls in order to establish appropriate standards for tools composing ClaCoS battery.
this project is to assess relevance of ClaCoS in autism compared to healthy controls, and to analyze links between social cognition and both neurocognition and symptoms, (2) to collect data in a large sample of healthy controls in order to establish appropriate standards for tools composing ClaCoS battery.
this project is to assess relevance of ClaCoS in autism compared to healthy controls, and to analyze links between social cognition and both neurocognition and symptoms, (2) to collect data in a large sample of healthy controls in order to establish appropriate standards for tools composing ClaCoS battery.